Sfoglia per Autore
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial
2025 Cairoli, R; Gatti, A; Grillo, G; Stefanucci, M; Di Camillo, B; Fumagalli, M; Krampera, M; Nadali, G; Zappasodi, P; Borlenghi, E; Todisco, E; Ubezio, M; Bernardi, M; Molteni, A; Basilico, C; Turrini, M; Greco, R; Mancini, V; Riva, M; Bernasconi, D; Brando, B; Veronese, S; Beghini, A
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection
2025 Travi, G; Peracchi, F; Merli, M; Ravano, E; Frustaci, A; Deodato, M; Fanti, D; Nava, A; Colombo, V; Bana, N; Rogati, C; Raimondi, A; Moioli, C; Pazzi, A; Vecchi, M; Motta, D; Rossotti, R; Oltolini, C; Crippa, F; Minetti, E; Vismara, C; Cairoli, R; Puoti, M
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study
2025 Polverelli, N; Zerbi, C; Benevento, M; Algeri, M; Algarotti, A; Angelucci, E; Balduzzi, A; Basiricò, M; Bassi, S; Battipaglia, G; Benedetti, E; Biffi, A; Bonifazi, F; Borghero, C; Bramanti, S; Brunello, L; Bresciani, P; Busca, A; Cairoli, R; Carluccio, P; Carobolante, F; Carella, A; Cavattoni, I; Cerretti, R; Chiappella, A; Chiusolo, P; Cimminiello, M; Corradini, P; Crescimanno, A; Cuoghi, A; Di Renzo, N; Fagioli, F; Fanin, R; Faraci, M; Federico, V; Geromin, A; Giaccone, L; Giacomazzi, A; Grassi, A; Grillo, G; Imovilli, A; Ingrosso, C; Iori, A; La Nasa, G; Leotta, S; Lupo Stanghellini, M; Mancini, G; Mariotti, J; Mele, A; Menconi, M; Merli, F; Mordini, N; Musso, M; Nozzoli, C; Pane, F; Parma, M; Pastano, R; Pastore, D; Patriarca, F; Picardi, A; Piemontese, S; Pierini, A; Piras, E; Porta, F; Porto, G; Prete, A; Prezioso, L; Proia, A; Raiola, A; Ricci, R; Roberto, M; Rosignoli, C; Russo, D; Salvatore, D; Santarone, S; Saporiti, G; Saraceni, F; Selleri, C; Serio, B; Skert, C; Sica, S; Spina, A; Tambaro, F; Tecchio, C; Terruzzi, E; Tumino, M; Vallisa, D; Zallio, F; Zecca, M; Taurino, A; Bianchessi, A; Defrancesco, I; Losi, G; Degrandi, E; Malagola, M; Castagna, L; Martino, M
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience
2025 Cairoli, R; Del Castello, L; Imbergamo, S; Pierdomenico, E; Papayannidis, C; Borlenghi, E; Vetro, C; Chiusolo, P; Fumagalli, M; Minotti, C; Marchesi, F; Bernardi, M; Musto, P; Fracchiolla, N; Candoni, A; Lunghi, M; Musso, M; Guolo, F; Mannina, D; Lico, A; Scattolin, A; Crugnola, M; Galimberti, S; Nadali, G; Turrini, M; Zappasodi, P; Todisco, E; Basilico, C; Grillo, G; Mancini, V; Riva, M; Bernasconi, D; Greco, R
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation
2025 Guolo, F; Fianchi, L; Martelli, M; Lussana, F; Grimaldi, F; Pilo, F; Rondoni, M; Filì, C; Minetto, P; Capelli, D; Chiusolo, P; Breccia, M; Mastaglio, S; Bernardi, M; Bocchia, M; Fumagalli, M; Galimberti, S; Mancini, V; Piccioni, A; Maurillo, L; Fracchiolla, N; Palmieri, R; Vetro, C; Papayannidis, C; Brunetti, L; Sperotto, A; Gigli, F; Zappasodi, P; Mulé, A; Patti, C; Borlenghi, E; Dargenio, M; Lessi, F; Cerrano, M; Cilloni, D; Isidori, A; Lunghi, M; Alati, C; Gurrieri, C; Riva, C; Marconi, G; Lotesoriere, I; Gatani, S; Scattolin, A; Caizzi, M; Perrone, S; Billio, A; Gherlinzoni, F; Mannelli, F; Gottardi, M; Cairoli, R; Candoni, A; Ferrara, F; Pagano, L; Lemoli, R; Venditti, A; Todisco, E
Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects
2025 Trojani, A; Pungolino, E; Di Camillo, B; Bossi, L; Palumbo, C; D'Adda, M; Perego, A; Turrini, M; Elena, C; Borin, L; Iurlo, A; Malato, S; Spina, F; Latargia, M; Spedini, P; Artale, S; Anghilieri, M; Carraro, M; Bucelli, C; Beghini, A; Cairoli, R
Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing–Neel Syndrome
2025 Frustaci, A; Zappaterra, A; Turri, G; Rossi, V; Deodato, M; Gambacorti‐passerini, C; Cairoli, R; Danesi, R; Tedeschi, A
Targeting CD38 to reduce anti-HLA antibody levels: A new and effective option to be integrated into desensitization protocols?
2025 Chiavetta, V; Soldarini, M; Cafro, A; Bertazzoni, P; Lando, G; Di Maggio, G; Sole, T; Pioltelli, M; Cuppari, I; Corso, A; Sulejmani, A; Cairoli, R; Volpato, E; Crocchiolo, R
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry-Based Study on Behalf of the “Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare” (GITMO)
2025 Defrancesco, I; Ferretti, V; Chiusolo, P; Russo, D; Nozzoli, C; Olivieri, A; Gambella, M; Cavattoni, I; Bramanti, S; Santarone, S; Fanin, R; Cairoli, R; Piemontese, S; Parma, M; Onida, F; Busca, A; Castagna, L; Cuoghi, A; Pastore, D; Mordini, N; Benedetti, F; Skert, C; Borghero, C; Iori, A; Fagioli, F; Pavone, V; Selleri, C; Cesaro, S; Musso, M; Ladetto, M; Vallisa, D; Carluccio, P; Picardi, A; Tozzi, M; Biffi, A; Milone, G; Faraci, M; Prete, A; Prezioso, L; Risitano, A; Tambaro, F; Tintori, V; Galieni, P; Pane, F; Zerbi, C; Bianchessi, A; Losi, G; Romano, F; Taurino, A; Oldani, E; Polverelli, N; Bonifazi, F; Martino, M
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy
2025 Mosna, F; Borlenghi, E; Litzow, M; Byrd, J; Papayannidis, C; Tecchio, C; Ferrara, F; Marcucci, G; Cairoli, R; Morgan, E; Gurrieri, C; Yeung, C; Deeg, H; Capelli, D; Candoni, A; Gotlib, J; Lunghi, M; Pullarkat, S; Lanza, F; Galimberti, S; Forghieri, F; Venditti, A; Festuccia, M; Audisio, E; Marvalle, D; Rigolin, G; Roti, G; Dibona, E; Visani, G; Albano, F; Eisfeld, A; Valent, P; Huls, G; Borthakur, G; Krampera, M; Martinelli, G; Kröger, N; Sperotto, A; Gottardi, M
Lymphoma’s last therapeutic option: Freeze it!
2024 Bassi, G; Ferrari, M; Vanzulli, A; Cantoni, S; Cairoli, R
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination.—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
2024 Rossi, G; Borlenghi, E; Zappasodi, P; Lussana, F; Bernardi, M; Basilico, C; Molteni, A; Lotesoriere, I; Turrini, M; Frigeni, M; Fumagalli, M; Cozzi, P; Gigli, F; Cattaneo, C; Fracchiolla, N; Riva, M; Martini, G; Mancini, V; Cairoli, R; Todisco, E
Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study
2024 Manghisi, B; Borin, L; Monaco, M; Sacco, G; Antolini, L; Mantegazza, R; Barichello, M; Mazza, U; Zappasodi, P; Onida, F; Arcaini, L; Cairoli, R; Gambacorti Passerini, C
Exploring the administrative burden faced by hematologists: a comprehensive study in Italy
2024 Petruzzelli, D; Vignetti, M; Trasarti, S; Sportoletti, P; Della Torre, S; Cairoli, R; Leone, F; Pompilio, G; Gullì, M; Brown Hajdukova, E; Integlia, D
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management
2024 Cavazza, G; Motto, C; Regna-Gladin, C; Travi, G; Di Gennaro, E; Peracchi, F; Monti, B; Corti, N; Greco, R; Minga, P; Riva, M; Rimoldi, S; Vecchi, M; Rogati, C; Motta, D; Pazzi, A; Vismara, C; Bandiera, L; Crippa, F; Mancini, V; Sessa, M; Oltolini, C; Cairoli, R; Puoti, M
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
2024 Trojani, A; Beghini, A; Bossi, L; Stefanucci, M; Palumbo, C; Greco, A; Frustaci, A; Di Camillo, B; Cairoli, R
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
2024 Zeidan, A; Ando, K; Rauzy, O; Turgut, M; Wang, M; Cairoli, R; Hou, H; Kwong, Y; Arnan, M; Meers, S; Pullarkat, V; Santini, V; Malek, K; Kiertsman, F; Niolat, J; Ramos, P; Menssen, H; Fenaux, P; Miyazaki, Y; Platzbecker, U
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients
2024 Zappaterra, A; Civettini, I; Cafro, A; Pezzetti, L; Pierini, S; Anghilieri, M; Bellio, L; Bertazzoni, P; Grillo, G; Minga, P; Pioltelli, M; Ravano, E; Sassone, M; Viganò, C; Volpato, E; Gambacorti-Passerini, C; Rossini, S; Cairoli, R; Crocchiolo, R
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3
2024 Levis, M; Hamadani, M; Logan, B; Jones, R; Singh, A; Litzow, M; Wingard, J; Papadopoulos, E; Perl, A; Soiffer, R; Ustun, C; Ueda Oshima, M; Uy, G; Waller, E; Vasu, S; Solh, M; Mishra, A; Muffly, L; Kim, H; Mikesch, J; Najima, Y; Onozawa, M; Thomson, K; Nagler, A; Wei, A; Marcucci, G; Geller, N; Hasabou, N; Delgado, D; Rosales, M; Hill, J; Gill, S; Nuthethi, R; King, D; Wittsack, H; Mendizabal, A; Devine, S; Horowitz, M; Chen, Y; Agura, E; Altman, J; Anagnostopoulos, A; Anand, S; Artz, A; Aulitzky, W; Balderman, S; Ballen, K; Becker, M; Beguin, Y; Berkahn, L; Berneman, Z; Bhatt, V; Bilmon, I; Bonifazi, F; Briggs, A; Bruno, B; Brunstein, C; Byrne, M; Byrne, J; Cabrero, M; Cairoli, R; Carrum, G; Cerny, J; Chen, Y; Cheong, J; Ciceri, F; Colorado, M; Cook, R; Couriel, D; Craddock, C; Damon, L; Deol, A; Desbrosses, Y; Devine, S; Di Grazia, C; Di Stasi, A; Dias, A; Dorritie, K; Essell, J; Eto, T; Farag, S; Forcade, E; Frankfurt, O; Fujiwara, S; Fukuda, T; Fukushima, K; Furst, S; Goto, T; Hall, A; Hatta, S; Hicheri, Y; Horwitz, M; Hou, H; How, J; Howard, D; Hsu, W; Huynh, A; Irvine, D; Ishikawa, T; Jamieson, K; Jedrzejczak, W; Jethava, Y; Jimenez, A; Jung, C; Kanda, J; Karakasis, D; Kato, J; Kekre, N; Khera, N; Kim, H; Klein, A; Kobbe, G; Kornblit, B; Kota, V; Lachance, S; Leber, B; Lee, C; Lee, J; Levis, M; Lin, T; Litzow, M; Liu, T; Martelli, M; Martinez, C; Matsuoka, K; Mccarty, J; Mendez, L; Michelis, F; Mikesch, J; Mineishi, S; Mishra, A; Mohty, M; Moors, I; Motyckova, G; Mueller, L; Muffly, L; Najima, Y; Nakamae, H; Nakano, N; Nathan, S; Nicholson, E; Norkin, M; Ogawa, Y; Olesen, G; Oluwole, O; Onozawa, M; Pantin, J; Papadopoulos, E; Paulson, K; Pemberton, L; Perera, T; Perl, A; Piatkowska-Jakubas, B; Poire, X; Protheroe, R; Rambaldi, A; Ritchie, D; Ross, K; Rubio, M; Santarone, S; Sanz Caballer, J; Sawa, M; Schaar, D; Scheid, C; Schriber, J; Seropian, S; Shah, N; Shah, N; Shore, T; Gil, J; Singh, A; Sobecks, R; Socie, G; Soiffer, R; Solh, M; Sprague, K; Spyridonidis, A; Stelljes, M; Stiff, P; Stuart, R; Tanaka, M; Tandra, A; Tholouli, E; Thomas, X; Thomson, K; Tiribelli, M; Tomlinson, B; Tsirigotis, P; Tzachanis, D; Uchida, N; Ueda, M; Ustun, C; Uy, G; Valcarcel Ferreiras, D; Vasu, S; Wagner, E; Waller, E; Watson, A; Weisdorf, D; Wingard, J; Wolschke, C; Wrobel, T; Yakoub-Agha, I; Yamauchi, T; Yared, J; Yeh, S; Yoon, S; Yoshihara, S; Null, N
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial
2024 Tedeschi, A; Frustaci, A; Condoluci, A; Coscia, M; Chiarle, R; Zinzani, P; Motta, M; Gaidano, G; Quaresmini, G; Scarfò, L; Catania, G; Deodato, M; Jones, R; Tabanelli, V; Griggio, V; Stüssi, G; Calleri, A; Pini, K; Cairoli, R; Zenz, T; Signori, A; Zucca, E; Rossi, D; Montillo, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile